Clinical Trial Detail

NCT ID NCT01732640
Title A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

hypopharynx cancer

oral squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

Therapies

Afatinib + Carboplatin + Paclitaxel

Cisplatin

Age Groups: adult

No variant requirements are available.